Skip to content

P200TxE Diseased Eye Image Collection

P200TxE Diseased Eye Image Collection

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06269666
Enrollment
100
Registered
2024-02-21
Start date
2024-01-31
Completion date
2024-10-09
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Disease

Brief summary

The primary objective is to collect images on the P200TxE device in diseased eyes.

Interventions

DEVICEP200TxE

SLO and OCT imaging

Sponsors

Optos, PLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female subjects 22 years of age or older who have full legal capacity to subject on the date the informed consent is signed; 2. Subjects who can follow the instructions by the clinical staff at the clinical site; 3. Subjects who agree to participate; 4. Subjects who have been diagnosed with retinal pathology and/or glaucoma that affects the posterior pole region including the macula and/or optic nerve. For glaucoma subjects: a. Glaucoma subjects who have a history of visual field loss and RNFL or optic nerve changes.

Exclusion criteria

1. Subjects unable to tolerate ophthalmic imaging; 2. Subjects with ocular media not sufficiently clear to obtain acceptable images.

Design outcomes

Primary

MeasureTime frame
Number of images1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026